Abstract
Recent advances in next-generation sequencing strategies have led to the discovery of many novel disease genes. We describe here a non-consanguineous family with two affected boys presenting with early onset of severe axonal neuropathy, optic atrophy, intellectual disability, auditory neuropathy and chronic respiratory and gut disturbances. Whole-exome sequencing (WES) was performed on all family members and we identified compound heterozygous variants (c.[760C>A];[1528G>C];p.[(Gln254Lys);(Ala510Pro)] in the polyribonucleotide nucleotidyltransferase 1 (PNPT1) gene in both affected individuals. PNPT1 encodes the polynucleotide phosphorylase (PNPase) protein, which is involved in the transport of small RNAs into the mitochondria. These RNAs are involved in the mitochondrial translation machinery, responsible for the synthesis of mitochondrially encoded subunits of the oxidative phosphorylation (OXPHOS) complexes. Both PNPT1 variants are within highly conserved regions and predicted to be damaging. These variants resulted in quaternary defects in the PNPase protein and a clear reduction in protein and mRNA expression of PNPT1 in patient fibroblasts compared with control cells. Protein analysis of the OXPHOS complexes showed a significant reduction in complex I (CI), complex III (CIII) and complex IV (CIV). Enzyme activity of CI and CIV was clearly reduced in patient fibroblasts compared with controls along with a 33% reduction in total mitochondrial protein synthesis. In vitro rescue experiments, using exogenous expression of wild-type PNPT1 in patient fibroblasts, ameliorated the deficiencies in the OXPHOS complex protein expression, supporting the likely pathogenicity of these variants and the importance of WES in efficiently identifying rare genetic disease genes.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ng SB, Turner EH, Robertson PD et al: Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461: 272–276.
Caliskan M, Chong JX, Uricchio L et al: Exome sequencing reveals a novel mutation for autosomal recessive non-syndromic mental retardation in the TECR gene on chromosome 19p13. Hum Mol Genet 2011; 20: 1285–1289.
Gilissen C, Arts HH, Hoischen A et al: Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome. Am J Hum Genet 2010; 87: 418–423.
Ng SB, Buckingham KJ, Lee C et al: Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010; 42: 30–35.
Menezes MJ, Riley LG, Christodoulou J : Mitochondrial respiratory chain disorders in childhood: insights into diagnosis and management in the new era of genomic medicine. Biochim Biophys Acta 2014; 1840: 1368–1379.
Lake NJ, Compton AG, Rahman S, Thorburn DR : Leigh syndrome: One disorder, more than 75 monogenic causes. Ann Neurol 2016; 79: 190–203.
von Ameln S, Wang G, Boulouiz R et al: A mutation in PNPT1, encoding mitochondrial-RNA-import protein PNPase, causes hereditary hearing loss. Am J Hum Genet 2012; 91: 919–927.
Vedrenne V, Gowher A, De Lonlay P et al: Mutation in PNPT1, which encodes a polyribonucleotide nucleotidyltransferase, impairs RNA import into mitochondria and causes respiratory-chain deficiency. Am J Hum Genet 2012; 91: 912–918.
Sobreira N, Schiettecatte F, Boehm C, Valle D, Hamosh A : New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene. Hum Mutat 2015; 36: 425–431.
Frazier AE, Thorburn DR : Biochemical analyses of the electron transport chain complexes by spectrophotometry. Methods Mol Biol 2012; 837: 49–62.
McKenzie M, Lazarou M, Ryan MT : Analysis of respiratory chain complex assembly with radiolabeled nuclear- and mitochondrial-encoded subunits. Methods Enzymol 2009; 456: 321–339.
Sarkar D, Fisher PB : Polynucleotide phosphorylase: an evolutionary conserved gene with an expanding repertoire of functions. Pharmacol Ther 2006; 112: 243–263.
Sarkar D, Park ES, Emdad L, Randolph A, Valerie K, Fisher PB : Defining the domains of human polynucleotide phosphorylase (hPNPaseOLD-35 mediating cellular senescence. Mol Cell Biol 2005; 25: 7333–7343.
Sokhi UK, Bacolod MD, Dasgupta S et al: Identification of genes potentially regulated by human polynucleotide phosphorylase (hPNPaseold-35 using melanoma as a model. PLoS One 2013; 8: e76284.
Piwowarski J, Grzechnik P, Dziembowski A, Dmochowska A, Minczuk M, Stepien PP : Human polynucleotide phosphorylase, hPNPase, is localized in mitochondria. J Mol Biol 2003; 329: 853–857.
Borowski LS, Dziembowski A, Hejnowicz MS, Stepien PP, Szczesny RJ : Human mitochondrial RNA decay mediated by PNPase-hSuv3 complex takes place in distinct foci. Nucleic Acids Res 2013; 41: 1223–1240.
Das SK, Bhutia SK, Sokhi UK et al: Human polynucleotide phosphorylase (hPNPaseold-35: an evolutionary conserved gene with an expanding repertoire of RNA degradation functions. Oncogene 2011; 30: 1733–1743.
Wang G, Chen HW, Oktay Y et al: PNPASE regulates RNA import into mitochondria. Cell 2010; 142: 456–467.
Wu J, Li Z : Human polynucleotide phosphorylase reduces oxidative RNA damage and protects HeLa cell against oxidative stress. Biochem Biophys Res Commun 2008; 372: 288–292.
Acknowledgements
This work was supported by a scholarship to A Alodaib provided by the Academic and Training Affairs at King Faisal Specialist Hospital and Research Center and the Ministry of Higher Education (Riyadh, Saudi Arabia). This research was supported by Australian NHMRC Grant 1026891 (to JC), an NHMRC Principal Research Fellowship (to DRT) and an NHGRI Grant 1U54HG006542. Finally, we also gratefully acknowledge donations to JC by the Crane and Perkins families.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Alodaib, A., Sobreira, N., Gold, W. et al. Whole-exome sequencing identifies novel variants in PNPT1 causing oxidative phosphorylation defects and severe multisystem disease. Eur J Hum Genet 25, 79–84 (2017). https://doi.org/10.1038/ejhg.2016.128
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2016.128
This article is cited by
-
Polynucleotide phosphorylase protects against renal tubular injury via blocking mt-dsRNA-PKR-eIF2α axis
Nature Communications (2023)
-
Pnpt1 mediates NLRP3 inflammasome activation by MAVS and metabolic reprogramming in macrophages
Cellular & Molecular Immunology (2023)
-
TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease
Nature Communications (2023)
-
Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics
Current Rheumatology Reports (2020)
-
Dedicated surveillance mechanism controls G-quadruplex forming non-coding RNAs in human mitochondria
Nature Communications (2018)
